Global Gene Therapy for Rare Disease Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by ;
Approved Drugs - Tisagenlecleucel (Kymriah), Axicabtagene ciloleucel (Yescarta), Voretigene neparvovec (Luxturna) and Strimvelis, Pipeline Drugs - GT-AADC, Fidanacogene elaparvovec (SPK-9011), OTL-200, bb2121, AMT-061 and Others.Segmented by Therapeutic Application;
Oncology, Neurological Disorders, Ophthalmic Disorders, Hematological Disorders, Immunodeficiency Disorders, Metabolic Disorders and Others.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Gene Therapy for Rare Disease Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 108.6 |
2021 | 121.6 |
2022 | 145.7 |
2023 | 153.5 |
2024 | 169.9 |
2025 | 170.7 |
2026 | 191.2 |
2027 | 218.3 |
2028 | 221.5 |
2029 | 246.6 |
2030 | 265.6 |
In the year 2023, the Global Gene Therapy for Rare Disease Market was valued at USD 1,991.48 million. The size of this market is expected to increase to USD 9,602.96 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 25.2%.
Global Gene Therapy for Rare Disease Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Gene Therapy for Rare Disease Market |
Study Period | 2020 - 2030 |
Base Year (for Gene Therapy for Rare Disease Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Gene Therapy for Rare Disease Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Gene Therapy for Rare Disease Market Analysis
In this report, the Global Gene Therapy for Rare Disease Market has been segmented by , Therapeutic Application and Geography.
Global Gene Therapy for Rare Disease Market, Segmentation by
The Global Gene Therapy for Rare Disease Market has been segmented by into Approved Drugs and Pipeline Drugs. The complete Global Gene Therapy for Rare Disease Market segmentation by can be seen below:
- Global Gene Therapy for Rare Disease Market, By By Drug
- Approved Drugs
- Tisagenlecleucel (Kymriah)
- Axicabtagene ciloleucel (Yescarta)
- Voretigene neparvovec (Luxturna)
- Strimvelis
- Pipeline Drugs
- GT-AADC
- Fidanacogene elaparvovec (SPK-9011)
- OTL-200
- bb2121
- AMT-061
- Others
- Approved Drugs
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the s mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Gene Therapy for Rare Disease Market, by (USD Million), 2020 - 2030
# | Approved Drugs | Pipeline Drugs |
---|---|---|
2020 | 108.2 | 65.3 |
2021 | 129.3 | 68.2 |
2022 | 134.9 | 70.9 |
2023 | 143.7 | 80.0 |
2024 | 171.8 | 83.9 |
2025 | 189.4 | 94.1 |
2026 | 210.7 | 104.8 |
2027 | 236.5 | 123.1 |
2028 | 272.9 | 129.7 |
2029 | 294.7 | 155.4 |
2030 | 332.4 | 158.1 |
Global Gene Therapy for Rare Disease Market, Segmentation by Therapeutic Application
The Global Gene Therapy for Rare Disease Market has been segmented by Therapeutic Application into Oncology, Neurological Disorders, Ophthalmic Disorders, Hematological Disorders, Immunodeficiency Disorders, Metabolic Disorders and Others. The complete Global Gene Therapy for Rare Disease Market segmentation by Therapeutic Application can be seen below:
- Global Gene Therapy for Rare Disease Market, By Therapeutic Application
- Oncology
- Neurological Disorders
- Ophthalmic Disorders
- Hematological Disorders
- Immunodeficiency Disorders
- Metabolic Disorders
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Therapeutic Applications mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Therapeutic Application is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Gene Therapy for Rare Disease Market, by Therapeutic Application (USD Million), 2020 - 2030
# | Oncology | Neurological Disorders | Ophthalmic Disorders | Hematological Disorders | Immunodeficiency Disorders | Metabolic Disorders | Others |
---|---|---|---|---|---|---|---|
2020 | 91.9 | 84.4 | 96.2 | 59.4 | 94.9 | 63.4 | 59.5 |
2021 | 109.1 | 86.5 | 106.7 | 64.4 | 97.5 | 64.7 | 68.1 |
2022 | 109.8 | 90.8 | 124.8 | 64.4 | 105.7 | 66.5 | 69.7 |
2023 | 112.5 | 108.9 | 141.5 | 73.0 | 121.6 | 69.6 | 74.2 |
2024 | 114.8 | 116.9 | 150.4 | 77.0 | 133.0 | 70.2 | 83.6 |
2025 | 132.8 | 119.2 | 151.6 | 87.5 | 151.0 | 71.7 | 85.6 |
2026 | 148.9 | 141.6 | 178.6 | 91.8 | 170.2 | 72.9 | 86.9 |
2027 | 163.8 | 143.5 | 192.5 | 108.7 | 197.6 | 80.3 | 94.6 |
2028 | 171.5 | 167.1 | 217.1 | 123.2 | 199.3 | 81.0 | 105.0 |
2029 | 178.7 | 189.9 | 223.7 | 139.9 | 219.1 | 86.7 | 112.4 |
2030 | 212.9 | 205.7 | 266.4 | 144.0 | 232.1 | 93.8 | 129.4 |
Global Gene Therapy for Rare Disease Market, Segmentation by Geography
In this report, the Global Gene Therapy for Rare Disease Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Gene Therapy for Rare Disease Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Gene Therapy for Rare Disease Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Gene Therapy for Rare Disease in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Gene Therapy for Rare Disease Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Gene Therapy for Rare Disease Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Gene Therapy for Rare Disease Market will be discussed in detail in the full report.
- The new opportunities in Global Gene Therapy for Rare Disease Market will be discussed in detail in the full report.
- Global Gene Therapy for Rare Disease Market Drivers will be discussed in detail in the full report.
- Global Gene Therapy for Rare Disease Market Restraints will be discussed in detail in the full report.
- Global Gene Therapy for Rare Disease Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Gene Therapy for Rare Disease Market. The opportunity map (by market segments; and Therapeutic Application) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Gene Therapy for Rare Disease Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Gene Therapy for Rare Disease Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Gene Therapy for Rare Disease Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Gene Therapy for Rare Disease Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Gene Therapy for Rare Disease Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Gene Therapy for Rare Disease Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Gene Therapy for Rare Disease Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Gene Therapy for Rare Disease Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Gene Therapy for Rare Disease Market include, BioMarin Pharmaceutical Inc., PTC Therapeutics Inc., Orchard Therapeutics Plc., uniQure N.V, Spark Therapeutics, Inc., Bluebird Bio, Inc., Juno Therapeutics Inc. (Celgene Corporation) and Novartis International AG.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By By Drug
- Market Snapshot, By Therapeutic Application
- Market Snapshot, By Region
- Market Opportunity Map
- Global Gene Therapy for Rare Disease Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Gene Therapy for Rare Disease Market, By By Drug, 2022- 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Approved Drugs
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Tisagenlecleucel (Kymriah)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Axicabtagene ciloleucel (Yescarta)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Voretigene neparvovec (Luxturna)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Strimvelis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Tisagenlecleucel (Kymriah)
- Pipeline Drugs
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- GT-AADC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Fidanacogene elaparvovec (SPK-9011)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- OTL-200
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- bb2121
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- AMT-061
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- GT-AADC
- Approved Drugs
- Global Gene Therapy for Rare Disease Market, By Therapeutic Application, 2022- 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Ophthalmic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Immunodeficiency Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Oncology
- Global Gene Therapy for Rare Disease Market, By Geography, 2022- 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By , 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2020 - 2030 (USD Million)
- Brazil
- North America
- Global Gene Therapy for Rare Disease Market, By By Drug, 2022- 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- BioMarin Pharmaceutical Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- PTC Therapeutics Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Orchard Therapeutics Plc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- uniQure N.V
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Spark Therapeutics, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bluebird Bio, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Juno Therapeutics Inc. (Celgene Corporation)
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novartis International AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- BioMarin Pharmaceutical Inc.
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global General Anesthesia Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global General Anxiety Disorder Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Generic Oncology Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Generic Oncology Sterile Injectable Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%